Literature DB >> 18702646

Local clustering of PRSS1 R122H mutations in hereditary pancreatitis patients from Northern Germany.

Frank Ulrich Weiss1, Martin Zenker, Arif Bülent Ekici, Peter Simon, Julia Mayerle, Markus M Lerch.   

Abstract

OBJECTIVE: The R122H mutation represents the most common point mutation of the cationic trypsinogen gene (PRSS1) in patients with hereditary pancreatitis (HP; Online Mendelian inheritance in man [OMIM] 167800), a rare variety of chronic pancreatitis. We identified a large number of HP families carrying this mutation in a confined region of Northern Germany within a 100-km radius. This apparent clustering could be due to the inheritance from a common ancestor (founder effect).
METHODS: To address this question, we genotyped SNPs in close vicinity of the PRSS1 locus and determined common haplotypes.
RESULTS: In members from 10 unrelated HP families (all R122H-positive), we found 7 different haplotypes to segregate with the R122H mutation.
CONCLUSIONS: This virtually excludes a founder effect and suggests the presence of a mutational hot spot in codon 122 of the PRSS1 gene. An ascertainment bias of a large-volume referral center may have contributed to the locally increased detection of HP cases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18702646     DOI: 10.1111/j.1572-0241.2008.02003.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  2 in total

1.  Intragenic duplication: a novel mutational mechanism in hereditary pancreatitis.

Authors:  Maiken T Joergensen; Andrea Geisz; Klaus Brusgaard; Ove B Schaffalitzky de Muckadell; Péter Hegyi; Anne-Marie Gerdes; Miklós Sahin-Tóth
Journal:  Pancreas       Date:  2011-05       Impact factor: 3.327

2.  Hereditary Pancreatitis in the United States: Survival and Rates of Pancreatic Cancer.

Authors:  Celeste A Shelton; Chandraprakash Umapathy; Kimberly Stello; Dhiraj Yadav; David C Whitcomb
Journal:  Am J Gastroenterol       Date:  2018-07-18       Impact factor: 10.864

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.